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Through the Human Connectome Project (HCP) our understanding of the functional connectome of the healthy
brain has been dramatically accelerated. Given the pressing public health need, we must increase our under-
standing of how connectome dysfunctions give rise to disordered mental states. Mental disorders arising from
high levels of negative emotion or from the loss of positive emotional experience affect over 400 million people
globally. Such states of disordered emotion cut across multiple diagnostic categories of mood and anxiety dis-
orders and are compounded by accompanying disruptions in cognitive function. Not surprisingly, these forms of
psychopathology are the leading cause of disability worldwide. The Research Domain Criteria (RDoC) initiative
spearheaded by NIMH offers a framework for characterizing the relations among connectome dysfunctions,
anchored in neural circuits and phenotypic profiles of behavior and self-reported symptoms. Here, we report on
our Connectomes Related to Human Disease protocol for integrating an RDoC framework with HCP protocols to
characterize connectome dysfunctions in disordered emotional states, and present quality control data from a
representative sample of participants. We focus on three RDoC domains and constructs most relevant to
depression and anxiety: 1) loss and acute threat within the Negative Valence System (NVS) domain; 2) reward
valuation and responsiveness within the Positive Valence System (PVS) domain; and 3) working memory and cognitive
control within the Cognitive System (CS) domain. For 29 healthy controls, we present preliminary imaging data:
functional magnetic resonance imaging collected in the resting state and in tasks matching our constructs of
interest (“Emotion”, “Gambling” and “Continuous Performance” tasks), as well as diffusion-weighted imaging. All
functional scans demonstrated good signal-to-noise ratio. Established neural networks were robustly identified in
the resting state condition by independent component analysis. Processing of negative emotional faces signifi-
cantly activated the bilateral dorsolateral prefrontal and occipital cortices, fusiform gyrus and amygdalae. Reward
elicited a response in the bilateral dorsolateral prefrontal, parietal and occipital cortices, and in the striatum.
Working memory was associated with activation in the dorsolateral prefrontal, parietal, motor, temporal and
insular cortices, in the striatum and cerebellum. Diffusion tractography showed consistent profiles of fractionaly and Behavioral Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA.
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L. Tozzi et al. NeuroImage 214 (2020) 116715anisotropy along known white matter tracts. We also show that results are comparable to those in a matched
sample from the HCP Healthy Young Adult data release. These preliminary data provide the foundation for
acquisition of 250 subjects who are experiencing disordered emotional states. When complete, these data will be
used to develop a neurobiological model that maps connectome dysfunctions to specific behaviors and symptoms.Fig. 1. Meta-analytic activation maps associated with our RDoC constructs of
interest. A Neurosynth (Yarkoni et al., 2011) search was conducted on the
August 21, 2019 to obtain activation maps for the keywords: negative affect
(negative valence systems), reward (positive valence systems), working memory
and cognitive control (merged into a single cognitive systems map) and default
mode (cross-cutting elements). Association Z maps were thresholded at p false1. Introduction
Emotional disorders such as depression, generalized anxiety, social
anxiety and phobias affect over 400 million people globally and are the
leading cause of disability (Whiteford et al., 2013). In the US alone, the
suicide rate among young adults ages 15–24 has tripled since the 1950s
(Murphy et al., 2017); moreover, depression exacts an annual cost of
$201 billion (Roehrig, 2016). In a recent review, we documented the
highly prevalent comorbidity of these emotional disorders, which com-
pounds their impact (Goldstein-Piekarski et al., 2016; Gorman, 1996).
Indeed, these disorders share common features such as experiences of
increased negative affect (sad mood, negative biases, anxiety), decreased
positive affect (anhedonia), and cognitive impairments (poor working
memory and cognitive control, ruminations).
There is an urgent public need to reduce the enormous burden of
emotional disorders. One fundamental step to do so is the development of
biological models for their more effective classification and treatment.
Motivated by this goal we launched the Human Connectome Project for
Disordered Emotional States (HCP-DES). Based on accumulating evi-
dence from human neuroimaging, our premise is that dysfunctions in
networks that govern emotional and cognitive processes contribute to the
symptoms and behaviors that characterize disordered emotional states
(Van Essen and Barch, 2015; Williams, 2017, 2016). Advances in mag-
netic resonance imaging (MRI) and in computation spearheaded by large
collaborative efforts such as the Human Connectome Project (HCP; Van
Essen et al., 2013) provide tools that are ideally suited to elucidate the
macroscale organization of the brain. As one of the “Human Connectome
Studies Related to Human Disease” projects, HCP-DES will take advan-
tage of the infrastructure developed by the HCP for the acquisition,
analysis and sharing of data. We will leverage these tools to systemati-
cally quantify macroscale networks of regions (“circuits”) that charac-
terize emotional disorders at the individual level.
Emotional disorders are traditionally defined by diagnostic criteria
that rely on discrete categories of symptoms. Consistent with the
Research Domain Criteria (RDoC) framework (Cuthbert and Insel, 2013;
Insel et al., 2010), our goal is to instead characterize emotional disorders
based on measures that are grounded in cognitive and affective neuro-
science and that span various units of analysis. Moving beyond the cur-
rent categories of diagnosis, the HCP-DES will detail the associations
between circuit function and specific profiles of symptoms and behaviors.
In this paper we present an overview of the aims, methods, quality
control and data access policy of the HCP-DES, which uses the RDoC
framework to quantify transdiagnostic dysfunctions that characterize
disordered emotional states. Our goal is to provide a theoretical and
methodological foundation for researchers considering downloading the
data once it will be shared and to provide a preliminary overview of how
results from our imaging data compare data previously released by the
HCP.
2. Rationale: an RDoC framework for disordered emotional
states
In this section, we outline our hypotheses concerning how disordered
emotional states are characterized by dysfunction of constructs within
the RDoC negative valence, positive valence and cognitive systems.
These constructs will be the targets of our study and will be measured by
three units of analysis: circuits, behavior and self-report.22.1. Unit of analysis: circuits
See Fig. 1 for a meta-analysis-based summary of the circuits involved
in each of our systems of interest.
2.1.1. Negative valence systems
Within the negative valence systems domain, we will focus on the
constructs of acute and potential threat and loss, given their prominent
role in the symptomatology of emotional disorders (Ahmed et al., 2018;
Cuthbert and Insel, 2013; Insel et al., 2010). Acute/potential threat and
loss share their localization in affective networks that comprise the
amygdala, hippocampus, insula, anterior cingulate cortex (ACC) and
lateral prefrontal cortex (lPFC; (Kober et al., 2008; Robinson et al., 2014).
Altered activation and connectivity of these regions has been consistently
observed across multiple diagnostic categories of disordered emotional
states, including depression, generalized anxiety, social phobia, specific
phobia, and panic (Fonzo et al., 2015; Jaworska et al., 2015; Killgorediscovery rate <0.01.
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2.1.2. Positive valence systems
Because reductions in the inability to feel pleasure is a prominent
feature of some emotional disorders, we will focus on the reward valu-
ation and responsiveness constructs within the RDoC positive valence
systems domain. Reward processing networks are comprised by the
striatum, orbitofrontal cortex (OFC) and ventromedial prefrontal cortex
(vmPFC) and ACC (Haber and Knutson, 2010; Keren et al., 2018). When
measuring response to reward, depressed individuals show
hypo-activation of the striatum correlating to anhedonia (Hamilton et al.,
2012; Treadway and Zald, 2011) as well as changes in the activation of
the OFC, medial prefrontal/midfrontal regions, and ACC (Dichter et al.,
2012; Zhang et al., 2013).
2.1.3. Cognitive systems
Depression and anxiety are associated with cognitive symptoms such
as deficits in concentration, failure to inhibit ruminations and difficulties
suppressing negative emotions (Lam et al., 2014). Within the cognitive
systems domain, we will focus on the constructs of working memory and
cognitive control (Cuthbert and Kozak, 2013). These processes are sup-
ported by networks including the dorsolateral prefrontal cortex (DLFPC),
dorsal parietal cortex (DPC) and precentral gyrus (Niendam et al., 2012).
Research by several groups has shown that people with depression
hypo-activate the DLPFC and ACC during working memory tasks and
related cognitive control tasks (Elliott et al., 1997a,b; Korgaonkar et al.,
2013; Siegle et al., 2007). Patients affected by anxiety disorder also show
DLPFC hypo-activation during working memory tasks independently of
threat, which supports the transdiagnostic nature of this dysfunction
(Balderston et al., 2017; Fales et al., 2008). Hyper-connectivity of the
DLPFC with the dorsal parietal cortex (DPC) and with the ACC has also
been observed in depressed people during working memory tasks (Vasic
et al., 2009) and at rest (Shen et al., 2015). This is posited to reflect an
inability to engage in working memory or suppress internal thoughts.
2.1.4. Cross-cutting elements
In the RDoC framework, the Default Mode Network (DMN) is a
relevant element in multiple systems. During rest, the DMN tends to be
up-regulated, and other networks down-regulated. Up-regulation of the
DMN at rest is posited to reflect spontaneously generated self-perception
and states of readiness for external focus. In this role, the DMN interacts
with networks involved in processing of task-evoked responses such as
acute threat, reward and working memory (Cole et al., 2014; Fox et al.,
2005; Spreng et al., 2013). The DMN is defined by posterior hubs in the
posterior cingulate cortex (PCC) and angular gyrus (AG) and an anterior
hub centered in anterior medial prefrontal cortex (amPFC) (Greicius
et al., 2003; Raichle, 2015). Several studies report functional
hyper-activation and hyper-connectivity of the DMN in depression
(Hamilton et al., 2015) and anxiety (Qiu et al., 2011). Hyper-activation of
the frontal subnetwork of the DMN in particular has been associated with
maladaptive rumination (J. P. Hamilton et al., 2011b). DMN interactions
with other networks may also exacerbate states of emotional disorder.
For example, depression has been associated with positive correlations
(rather than anti-correlation) between the DMN and DLFPC working
memory networks (Bartova et al., 2015; Hwang et al., 2015; Sheline
et al., 2010). This positive correlation may reflect difficulties to suppress
ruminative thoughts and focus on tasks.
2.2. Unit of analysis: behavior
2.2.1. Negative valence systems
Behaviorally, acute and potential threat are related to the accuracy of
identification of emotional facial expressions. Several studies have shown
that individuals suffering from depression are less accurate at identifying
all emotions, especially happiness, sadness and neutral (Dalili et al.,
2015; Milders et al., 2010; Sanchez et al., 2017; Watters and Williams,32011). In addition, individuals with anxious depression, compared to
those with non-anxious depression, have been shown to have a dimin-
ished ability to recognize happy and sad facial expressions (Berg et al.,
2016). The RDoC construct of loss is associated with psychomotor
retardation and deficits in executive function (Insel et al., 2010).
Converging evidence points toward a deficit of executive function in
mood disorders as detected by several measures of processing speed,
shifting of attention and working memory (Walters and Hines-Martin,
2018).
2.2.2. Positive valence systems
At the behavioral level, positive valence systems are involved in re-
sponses to reward. Increasing evidence has characterized depression by
reduced positive emotional reactivity (Bylsma et al., 2008) and
reward-processing deficits (Eshel and Roiser, 2010). In behavioral
studies of reward, individuals with depression showed reduced reward
responsiveness (Pechtel et al., 2013) and deficits in reward-based deci-
sion making (Kunisato et al., 2012). Reduced reward learning has been
also demonstrated in patients with depression reporting high anhedonia
compared to those reporting low anhedonia. This deficit has been shown
to be associated with worse treatment outcomes (Vrieze et al., 2013).
2.2.3. Cognitive systems
Behavioral correlates of cognitive control impairment include
distractibility, impulsive behavior and slower processing of information.
Individuals with MDD show cognitive symptoms such as deficits in
concentration, failure to inhibit ruminations or inability to suppress
negative emotions (Lam et al., 2014). Several studies have linked
depression with deficits in psychomotor speed, attention, visual learning
and memory, attentional switching, verbal fluency and cognitive flexi-
bility (Lee et al., 2012). Depression has also been associated with
impaired cognitive performance on a range of tasks designed to assess
executive function, memory and attention (Rock et al., 2014). Similarly,
anxious patients also show reduced accuracy and longer reaction times
during cognitive tasks (Balderston et al., 2017).
2.3. Unit of analysis: self-report
Questionnaires designed to quantify the severity of anxiety disorders
and depression typically contain several items or subscales pertaining to
threat, loss, reward, and cognitive function. Pooling items from different
questionnaires has been shown to be a reliable method to identify un-
derlying symptom profiles which cut across categorical diagnoses (Gri-
sanzio et al., 2018).
2.3.1. Negative valence systems
Depressed patients usually present with complaints of persistently
decreased mood over the course of weeks or even months. They also
often note that they tend to interpret neutral or even positive events as
negative (negative emotional bias) (Hasler et al., 2004). Other frequently
reported symptoms include persistent irritability, pessimism, sadness,
hopelessness, self-blame, and guilt (Diagnostic and statistical manual of
mental disorders, 2013; Fried and Nesse, 2015).
2.3.2. Positive valence systems
Anhedonia, or loss of pleasure, is a core feature of depression. Self-
reported symptoms of anhedonia include reward insensitivity, lack of
positive mood and motivation, and loss of interest in positive experiences
(Diagnostic and statistical manual of mental disorders, 2013).
2.3.3. Cognitive systems
Cognitive dysfunction encompasses a broad spectrum of common
symptoms of depression and anxiety that negatively affect quality of life
and impact general functioning. For example, depressed patients often
complain about decreased productivity in the workplace, difficulties
concentrating, loss of memory and attention deficits (Knight and Baune,
L. Tozzi et al. NeuroImage 214 (2020) 1167152018). Several studies have shown that subjective reports of cognitive
impairment also correlate with symptoms pertaining to other domains,
such as decreased mood (Hill et al., 2016).
3. Research aims
The objective of HCP-DES is to use protocols harmonized with the
overarching HCP to elucidate the relationship between circuits, behavior
and self-reported symptoms cutting across conventional diagnoses of
depression and anxiety disorders. We will elucidate these relations using
both region-of-interest approaches and data-driven machine-learning.
Drawing on existing knowledge about circuit dysfunction in
emotional disorders and the RDoC framework, we hypothesize that
disordered emotional states will be associated with the following dis-
ruptions detectable at the circuit, behavioral and self-report units of
analysis, independent of clinical diagnosis: (a) hypo-connectivity of
networks for acute threat, behavioral threat dysregulation and self-
reported anxiety symptoms; (b) hypoactivation and hypo-connectivity
of networks for reward evaluation/responsiveness, behavioral hypo-
responsiveness to social reward and self-reported anhedonia; (c) hypo-
activation of networks for working memory, poorer executive function
performance and self-reported ruminations (d) dysfunction in brain cir-
cuits cross-cutting across all domains. Our secondary sub-aims are to
examine whether (i) disruption of functional circuits is related to struc-
tural changes in white matter fiber tracts; and (ii) network-symptom-
behavior relations predict clinical outcomes relevant to disability and
burden of illness over a 1-year follow-up.
4. Protocol: methods and design
4.1. Ethical approval
The Institutional Review Boards of Stanford University has approvedFig. 2. Study flow for healthy controls and clinical participants. Eligible healthy cont
scheduled for a visit, and finally conduct the in-person baseline visit. Additionally
additional cognitive testing and a clinical interview a year following their in-person
4this protocol (protocol #41837). A study coordinator thoroughly ex-
plains the protocol to participants and answers any questions before they
can provide informed consent to begin the study. The study is conducted
according to the principles of the Declaration of Helsinki (2008).4.2. Recruitment and screening
We will recruit 250 individuals experiencing symptoms of emotional
distress (clinical participants) and 50 individuals not experiencing any
symptoms of emotional distress (healthy controls). Having a large
number of clinical participants will allow us to capture the full spectrum
of dysfunctions in our constructs of interest and analyze our data as a
continuum ranging from the absence of symptoms (represented by our
control group) to severe manifestations. Our sample of controls will also
help us establish the extent of overlap between measures collected by
HCP-DES and HCP-HYA, to potentially use the latter dataset as an
extended pool of controls. All participants will be 18–35 years of age in
order to obtain data from individuals in the peak age range for emotional
disorders and to facilitate harmonization with the HCP Healthy Young
Adult dataset (Van Essen et al., 2013).
Participants will be recruited from the surrounding community using
flyers and social media advertisements (i.e., Facebook and Instagram
Ads). Fig. 2 details the study flow for healthy controls and clinical par-
ticipants. All participants will respond to an online screening survey
reviewed by a study coordinator to determine eligibility. Respondents
will provide information concerning demographics, any current or past
pharmacotherapy or psychotherapy, their medical history, MRI scanner
contraindications, anxiety and depression symptoms, and alcohol or
substance use. A summary of all inclusion and exclusion criteria is pre-
sented in Table 1. Importantly, levels of clinical symptoms will be
assessed by an in-house survey containing items from the DASS, MASQ,
BAI, BIS, and RRS scales (see Methods below). The survey is composed of
five categories (containing four items in each) selected to match each ofrols and clinical participants initially fill out an online screening survey, then are
, clinical participants fill out a brief survey every three months and conduct
baseline visit.
Table 1
Inclusion/Exclusion criteria for clinical participants and healthy control study
entry. All participants are screened via an online screening survey that is
reviewed by a study coordinator prior to establishing eligibility.
Clinical Participants and
Healthy Controls
Clinical Participants Only Healthy Controls Only
Inclusion Criteria
● Ages 18-35
● Fluent and literate in
English, and show non-
impaired intellectual
abilities to ensure
adequate comprehen-
sion of the task
instructions
● Written, informed
consent
● fMRI scanning
eligibility, including
no evidence of any
form of metal
embedded in the body
(e.g., metal wires, nuts,
bolts, screws, plates,
sutures)
● Report at least a
moderate degree of one
or more of the
following sections:
anhedonia, anxious
arousal, concentration
problems, rumination,
tension, as assessed
using questions from
the MASQ, BAI, RRS,
and BIS
● No significant history
of any psychiatric
disorders, substance
abuse, neurological
disorders, or
cardiovascular
disease
● No history of
pharmacologic or
behavioral treatment
(12 months duration
or longer) by a
specialty-trained
physician (psychia-
trist, neurologist,
cardiologist) or
mental health pro-
fessional (e.g., social
worker, clinical
psychologist)
Exclusion Criteria
● General medical
condition, disease or
neurological disorder
that is likely to
interfere with ability to
complete assessments
● History of physical
brain injury or blow to
the head resulting in
loss of consciousness
greater than 10 min
● Severe impediment to
vision, hearing and/or
hand movement that is
likely to interfere with
ability to complete the
assessments, or with
comprehension of
instructions or study
requirements
● Pregnant or
breastfeeding
● Any contraindication
to being scanned in the
3.0T scanner (i.e.,
pacemaker or
implanted device that
has not been cleared
for scanning)
● Lifetime history of
psychosis or psychotic
ideation
● Marijuana use in the
past two weeks
● Substance or alcohol
abuse within the past
12 months
● Presence of suicidal
ideations representing
imminent risk (defined
as endorsement of
specific suicidal plan
or current intent)
established by the
MINI-Plus
● Currently taking any
psychotropic
medications for a
mental health problem
(i.e., SSRIs,
benzodiazepines, etc.)
● Currently receiving
therapy by a trained
mental health
professional (i.e., social
worker, psychiatrist,
clinical psychologist)
for a mental health
problem equivalent to
2þ formal sessions in
the past month
● Current mania
Abbreviations: MASQ, Mood and Anxiety Symptom Questionnaire; BAI, Beck
Anxiety Inventory; RRS, Ruminative Responses Scale; BIS, Behavioral Inhibition
Scale; MINI-Plus, MINI-International Neuropsychiatric Interview.
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5the four constructs identified using a factor analysis of data from (Gri-
sanzio et al., 2018): anhedonia, anxious arousal, concentration, rumi-
nation, and tension. This survey will allow us to recruit a sample of
participants presenting with clinically relevant symptoms. In order to be
classified as a clinical participant, respondents will have to report that at
least one symptom related statement “often” or “almost always/always”
applied to them in the last two weeks and indicate that the symptoms
caused significant distress and/or impairment. In order to be classified as
a healthy control, respondents will have to report that symptom-related
statements applied to them only “occasionally” or “rarely/never” in the
last two weeks and indicate that any symptoms they may have experi-
enced did not cause significant distress or impairment. Further, inter-
ested clinical and healthy control participants must not be taking any
psychotropic medications for a mental health problem (i.e., SSRIs, ben-
zodiazepines, etc.) or receiving therapy by a trained mental health pro-
fessional (social worker, clinical psychologist, psychiatrist, etc.). This is
to avoid confounding our results, since antidepressant treatment has
been shown to affect brain function in our circuits of interest (Wessa and
Lois, 2015). For participants who will be eligible and interested, a study
coordinator will schedule an in-person visit to complete the baseline
assessment.
4.3. Data collection at baseline visit
At the baseline in-person visit at Stanford, we will collect medical
history and demographics, conduct two sessions of MRI, cognitive as-
sessments, and self-report questionnaires. Refer to Table 2 for the full list
of measures organized by RDoC construct. For additional self-reported
and observer-rated measures that are supported by other funding, see
Supplement. Every individual who participates in our study is given an
extensive list of resources at the end of his/her visit, including: a list of
mental health behavioral therapy services, online resources on how to
find a therapist, a list of mutual help group treatments, a list of crisis
hotlines, and information about our treatment studies that we are
currently conducting in the lab. Moreover, every individual who
completed our screening survey but is ineligible receives this same
comprehensive list of resources. Since this could prompt people to start a
treatment after the first visit, we closely ask about changes in treatment
or significant lifestyle changes during our follow-up visits. We will then
take this information into account when mapping different trajectories of
disease in time. Additionally, we strictly adhere to a suicidality protocol
that is implemented when we have reason to think that individuals are in
danger of harming themselves or have current active suicidal thoughts,
plans, or intentions. Trained medical doctors and/or clinical psycholo-
gists (who are current postdoctoral associates or faculty collaborators in
the lab) are available for consultation and assist when clinical evaluation
is warranted.
4.3.1. Medical history, diagnosis and demographics
At baseline, we will administer the Mini-International Neuropsychi-
atric Interview (MINI-Plus) to assess mood and anxiety disorders based
on Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and
International Statistical Classification of Diseases and Related Health
Problems (ICD-10) criteria (Sheehan et al., 1998). Diagnoses assessed
will include: Persistent Depressive Disorder, Major Depressive Episode,
Major Depressive Disorder, Major Depressive Disorder with Psychotic
Features, Manic Episode, Hypomanic Episode, Bipolar I Disorder, Bipolar
I Disorder with Psychotic Features, Bipolar II Disorder, Bipolar Disorder
NOS, Panic Disorder, Agoraphobia, Social Anxiety Disorder, Obsessive
Compulsive Disorder, Posttraumatic Stress Disorder, Psychotic Disorders,
Mood Disorder with Psychotic Features, Anorexia Nervosa, Bulimia
Nervosa, Binge-Eating Disorder, and Generalized Anxiety Disorder.
Research personnel will also obtain comprehensive information about
past and current medical history and additional sociodemographic data.
Table 2
Self-report and clinician-rated surveys, computerized cognitive tests of behavioral performance, and functional MRI paradigms organized by the RDoC subconstructs of
interest and relevant neural circuits.
Circuits Behavior Self-report Paradigm
Negative valence systems
Threat (acute/
potential)
Amygdala, hippocampus,
insula, ACC, lateral PFC
Facial emotion identification Anxiety fMRI HCP-Emotion task, explicit emotion
identification, implicit emotion priming, BAI,
BIS, MASQ-D30, PANASLoss Psychomotor speed, executive
function performance
Depressed mood
Positive valence systems
Reward
(responsiveness/
valuation)
Striatum, OFC, vmPFC,
ACC
Positive emotion reactivity, reward
responsiveness, reward learning
Anhedonia, lack of motivation fMRI HCP-Gambling task, MASQ-D30, PANAS,
BAS
Cognitive systems
Working memory DLPFC, DPC, precentral
gyrus
Memory performance Loss of memory fMRI working memory task, continuous
performance, picture sequence memory
Cognitive control Concentration, impulsive behavior,
speed of information processing,
attention
Difficulties with concentration,
reduced attention, lower
productivity
Flanker, dimensional change card sort, picture
vocabulary, list sorting, pattern comparison
processing speed
Cross-cutting elements
Default mode PCC, AG, amPFC Ruminations, inability to
suppress negative thoughts
fMRI resting state, RRS, SOFAS, CQOL, Brief
COPE
Abbreviations: ACC, Anterior Cingulate Cortex; PFC, Prefrontal Cortex; OFC, Orbitofrontal Cortex; vmPFC, Ventromedial Prefrontal Cortex; DLPFC, Dorsolateral Pre-
frontal Cortex; DPC, Dorsal Parietal Cortex; PCC, Posterior Cingulate Cortex; AG, Angular Gyrus; amPFC, Anterior Medial Prefrontal Cortex; HCP, Human Connectome
Project; BAI, Beck Anxiety Inventory; BIS, Behavioral Inhibition Scale; MASQ-30, Mood and Anxiety Symptom Questionnaire; PANAS, Positive and Negative Affect
Schedule; BAS, Behavioral Activation Scale; RRS, Ruminative Responses Scale; SOFAS, Social and Occupational Functioning Assessment Scale; CQOL, Current Quality of
Life; Brief COPE, Brief Coping Orientation to Problems Experienced Inventory.
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The participant will undergo the following MRI scans, divided in 2
sessions with a break in between. 1) Spin-echo fieldmaps, 2) Resting state
fMRI, 3) Emotion task fMRI, 4) Gambling task fMRI, 5) Selective working
memory task fMRI, 6) T1-weighted anatomical, 7) T2-weighted
anatomical 8) Spin-echo fieldmaps, 9) Resting state fMRI, 10)
Diffusion-weighted imaging. Before the scan, a practice run of each task
will be conducted on a computer outside of the scanner.
4.3.2.1. Negative valence systems. “Emotion” Task: This task from the
HCP has been found to elicit robust amygdala and dorsolateral prefrontal
activation (Barch et al., 2013; Hariri et al., 2002). Subjects are shown
blocks of trials that either ask them to 1) determine which of the two
faces (either angry or fearful expressions) presented on the bottom of the
screen match the face at the top of the screen, or 2) determine which of
the two shapes shown at the bottom of the screen match the shape at the
top of the screen. There are 3 face blocks and 3 shape blocks, with 6 trials
in each in which the stimulus is presented for 2 s with a 1 s intertrial
interval (ITI). Each block is preceded by a 3 s task cue (“shape” or “face”),
so that each block is 21 s long including the cue. Our contrast of interest
for generalized linear model (GLM) analyses will be face blocks > shape
blocks. One run of the task will be acquired in the first session, with
posterior-anterior phase encoding direction.
4.3.2.2. Positive valence systems. “Gambling” Task: The HCP-DES
adopts a version of the HCP gambling task modified to allow compari-
son of small and large gain and loss outcomes (Somerville et al., 2018). A
question mark is displayed on the screen and the participant must guess
whether a number is greater than or less than five (and indicate their
answer via button presses). If the participant identifies correctly, they
win money, and if they guess incorrectly, they lose money. At the end of
the task, 5 trials are randomly selected and summed together to deter-
mine the participant’s payment. Our contrast of interest for GLM analyses
will be face reward > punishment trials. One run of the task will be ac-
quired in the first session, with posterior-anterior phase encoding
direction.
4.3.2.3. Cognitive systems. “Continuous performance” Task: This task
has been used previously to probe working memory maintenance and
sustained attention functions in depression (Korgaonkar et al., 2013).6Participants are instructed to attend to yellow but not white letters and to
press a button when the same yellow letter appears twice in a row.
Stimuli are presented under three conditions: 30 sustained attention
stimuli in which yellow letters appear twice in a row and participants
respond to the consecutive yellow letter, 50 working memory stimuli in
which yellow letters appear randomly and not consecutively and par-
ticipants are required to maintain and update working memory without
responding to the letters and 40 perceptual baseline stimuli in which
to-be-ignored white letters are presented as a perceptual contrast to
yellow letters. Workingmemory stimuli are not presented in a design that
manipulates different levels of working memory demand. Our contrasts
of interest for GLM analyses will be consecutive yellow letters> baseline,
non-consecutive yellow letters > baseline and non-consecutive >
consecutive letters. One run of the task is acquired in the first session,
with posterior-anterior phase encoding direction.
4.3.2.4. Cross-cutting elements. Resting State: Participants will be
instructed to stare at a white cross on a black background. During this
time, their eyes will be monitored using an eye-tracker by the study
coordinator to ensure that the participant is not asleep. Four separate 5-
min runs of resting state data will be acquired, two with a posterior-
anterior phase encoding direction and the other two with a posterior-
anterior direction.
4.3.2.5. Acquisition details. Images will be acquired at the Stanford
Center for Cognitive and Neurobiological Imaging (CNI) on a GE Dis-
covery MR750 3T scanner using a Nova Medical 32-channel head coil.
Two spin-echo fieldmaps will be acquired at the beginning of each ses-
sion, one with a posterior-anterior phase encoding direction, the other
with an anterior-posterior direction. All fMRI scans will be conducted
using a blipped-CAIPI simultaneous multislice “multiband” acquisition
(Setsompop et al., 2012). A separate single-band scan is acquired before
each of the multiband acquisitions to provide calibration data for the
parallel image reconstruction which uses the split-slice-GRAPPA method
(Cauley et al., 2014).
1. Spin-echo fieldmaps: TE ¼ 55.5 ms, TR ¼ 6 s, FA ¼ 90, acquisition
time¼ 18 s, field of view¼ 220.8 220.8 mm, 3Dmatrix size¼ 92
92 60, slice orientation¼ axial, angulation to anterior commissure -
posterior commissure (AC-PC) line, phase encoding ¼ AP and PA,
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spacing ¼ 0.54 ms, voxel size ¼ 2.4 mm isotropic.
2. Single-band calibration: TE ¼ 30 ms, TR ¼ 4.4 s, FA ¼ 90, acqui-
sition time ¼ 13 s, field of view ¼ 220.8  220.8 mm, 3D matrix size
¼ 92  92  60, slice orientation ¼ axial, angulation to AC-PC line,
phase encoding ¼ PA, receiver bandwidth ¼ 250 kHz, readout
duration ¼ 49.14 ms, echo spacing ¼ 0.54 ms, number of volumes ¼
4, voxel size ¼ 2.4 mm isotropic.
3. Multiband fMRI: TE ¼ 30 ms, TR¼ 0.71 s, FA ¼ 54, acquisition time
¼ 5:12 (rest), 2:25 (emotion task), 3:44 (gambling task), 5:08
(continuous performance task), field of view¼ 220.8 220.8mm, 3D
matrix size ¼ 92  92  60, slice orientation ¼ axial, angulation to
AC-PC line, phase encoding ¼ PA, receiver bandwidth ¼ 250 kHz,
readout duration ¼ 49.14 ms, echo spacing ¼ 0.54 ms, number of
volumes ¼ rest ¼ 440, emotion ¼ 204, gambling ¼ 316, CPT ¼ 434,
multiband factor ¼ 6, calibration volumes ¼ 2, voxel size ¼ 2.4 mm
isotropic. Compared to HCP-HYA parameters, this sequence had
lower multiband factor (6 versus 8) and larger voxel size (2.4 versus
2) to increase the signal to noise ratio, especially in our subcortical
structures of interest.
4. T1-weighted: TE ¼ 3.548 ms, MPRAGE TR ¼ 2.84s, FA ¼ 8, acqui-
sition time ¼ 8:33, field of view ¼ 256  256 mm, 3D matrix size ¼
320  320  230, slice orientation ¼ sagittal, angulation to AC-PC
line, receiver bandwidth ¼ 31.25 kHz, fat suppression ¼ no, motion
correction ¼ PROMO, voxel size ¼ 0.8 mm isotropic.
5. T2-weighted: TE ¼ 74.4 ms, TR ¼ 2.5 s, FA ¼ 90, acquisition time ¼
5:42, field of view ¼ 240  240 mm, 3D matrix size ¼ 320  320 
216, slice orientation ¼ sagittal, angulation to AC-PC line, receiver
bandwidth ¼ 125 kHz, fat suppression ¼ no, motion correction ¼
PROMO, voxel size ¼ 0.8 mm isotropic.
6. Diffusion-weighted: A total of 4 acquisitions, TE¼ 80ms, TR¼ 3.2 s,
FA ¼ 77, acquisition time ¼ 4:48, field of view ¼ 210  210 mm, 3D
matrix size¼ 140  140 84, slice orientation¼ axial, angulation to
AC-PC line, phase encoding ¼ AP and PA, receiver bandwidth ¼ 125
kHz, readout duration ¼ 113.12 ms, echo spacing ¼ 0.808 ms, di-
rections¼ 74, 74, 76, 76, b-values¼ 1500, 3000, number of b0¼ 5, 5,
5, 5, multi-shell, equal spacing, single spin echo, cardiac gating ¼ no,
calibration volumes ¼ 2, voxel size ¼ 1.5 mm isotropic.
4.3.3. Computerized tests of behavioral performance
4.3.3.1. WebNeuro tasks. These tasks will be executed on a desktop
computer by the participant and described in detail in (Silverstein et al.,
2007; Watters and Williams, 2011). The software used to run the tasks
includes standardized task instructions. Psychometric properties have
been established for each of these tests, including norms, construct
validation, validation against traditional neuropsychological tests tap-
ping equivalent functions, test-retest reliability, and consistency across
cultures (Williams et al., 2016). For each test, we will record accuracy
and reaction time.
4.3.3.1.1. Positive and negative valence systems.
1. Explicit emotion identification: Participants identify the emotion of
96 facial expressions (neutral, happy, sad, fear, anger, or disgust).
2. Implicit emotion priming: 24 of the photographs from the explicit
emotion identification task are randomly selected for each participant
and are presented a second time. Each will be shown beside one of 24
new photographs showing a different individual but of the same sex
and emotion. For each pairing, participants indicate which of the two
faces they have seen in the previous task.
4.3.3.1.2. Cognitive systems.
1. Continuous performance test: A series of 125 similar looking letters
are presented to the participant on the computer screen. If the same
letter appears twice in a row, the participant required to press the
spacebar.74.3.3.2. NIH toolbox tasks. These behavioral tasks are executed on an
iPad with the study coordinator and described in detail in (Weintraub
et al., 2013).
4.3.3.2.1. Cognitive systems.
1. Flanker Inhibitory Control and Attention Test: A measure of ex-
ecutive function. This task requires the participant to focus on a
particular stimulus while inhibiting attention to the stimuli flanking it
(40 trials).
2. Dimensional Change Card Sort Test: A measure of executive
function, specifically cognitive flexibility and attention. Two target
pictures are presented that vary along two dimensions (e.g., shape
and color). Subjects are asked the match a series of bivalent test
pictures (e.g., yellow balls and blue trucks) to the target pictures, first
according to one dimension (e.g., color) and then, after a number of
trials, according to the other dimension (e.g., shape) (40 trials).
3. Picture Sequence Memory Test (Form A): A measure of episodic
memory, whereby sequences of pictured objects and activities are
presented in a specific order, and the participant is asked to reproduce
the sequence of pictures that is shown on the screen.
4. Picture Vocabulary Test: A measure of receptive vocabulary
administered in a computer-adaptive test (CAT) format. The task is to
pick a picture that best matches a spoken word.
5. List Sorting Working Memory Test: A measure of working memory.
This task requires the participant to recall and sequence different
visually and orally presented stimuli. Pictures of different foods and
animals are displayed with both an accompanying audio recording
and written text that name the item. The participant is asked to say
the items back to the study coordinator in size order from smallest to
largest.
6. Pattern Comparison Processing Speed Test: A measure of pro-
cessing speed. This task requires participants to discern whether two
side-by-side pictures are the same or not (130 items).
4.3.4. Self-report measures
The majority of our self-report measures are presented in a comput-
erized format using the REDCap database. Scores for individual items are
recorded and then summed automatically according to symptom cluster
and scale definitions. An exception to automated scoring is the SOFAS,
which is rated by study coordinators.
4.3.4.1. Negative and positive valence systems.
1. Beck Anxiety Inventory (BAI): A 21-item self-report inventory for
measuring the severity of common symptoms of anxiety that the
participant has had during the past week, such as numbness and
tingling, sweating not due to heat, and fear of the worst happening
(Beck et al., 1988).
2. Behavioral Inhibition Scale (BIS): A 7-item scale assessing behav-
ioral inhibition (i.e., concern over and reactivity to aversive events)
on a 4-point scale ranging from 1 to 4 (Carver and White, 1994).
3. Mood and Anxiety Symptom Questionnaire short form (MASQ-
D30): A 30-item questionnaire based on the Tripartite Model of
Anxiety and Mood that provides scores in three domains: General
Distress, Anhedonic Depression, and Anxious Arousal. The questions
refer to how the subject has been feeling in the past two weeks
(Wardenaar et al., 2010).
4. Positive and Negative Affect Schedule (PANAS): A 20-item ques-
tionnaire that measures positive and negative affect on a 5-point scale
ranging from 1 to 5 (Watson et al., 1988).
5. Behavioral Activation System Scale (BAS): A 13-item scale
assessing behavioral activation (i.e., reward responsiveness, drive,
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White, 1994).
4.3.4.2. Cross-cutting elements.
1. Ruminative Responses Scale (RRS): A 22-item self-report ques-
tionnaire that assesses two aspects of rumination; brooding and
reflecting pondering. It is scored on a 4-point scale ranging from 1 to 4
(Parola et al., 2017).
2. Social and Occupational Functioning Assessment Scale (SOFAS):
The SOFAS is a derivative of the Global Adjustment Scale and reflects
the individual’s level of social and occupational functioning, rated by
a study coordinator on a scale between 0 and 10 (Morosini et al.,
2000).
3. Current Quality of Life (CQOL): A measure of an individual’s gen-
eral mental and physical health during the previous 30 days (Burck-
hardt and Anderson, 2003). Available in the Phenotypes and
eXposures (PhenX) Toolkit (C. M. Hamilton et al., 2011a).
4. Brief Coping Orientation to Problems Experienced Inventory
(Brief COPE): A 28-item questionnaire assessing usage of various
coping strategies (Carver, 1997). Available in the PhenX Toolkit (C.
M. Hamilton et al., 2011).
4.4. Follow-up outcome measures
Every 3 months for one year after the in-person baseline visit (4 times
total), clinical participants will complete a 10–15 min online question-
naire regarding symptoms, treatments, and life events. The PHQ-9, GAD-
7, and SWLS are also included. In addition, one year after the baseline
assessment, clinical participants will complete a diagnostic interview
over the telephone (MINI-Plus) and cognitive testing remotely
(WebNeuro).
4.5. Data management and access
Neuroimaging data will be managed using the quality control and
data management infrastructure Flywheel (https://flywheel.io/) at the
Stanford CNI. For the computerized behavioral tests, the computer will
register each response and collects these with time stamps to a log file.
For the questionnaires, each self-reported response entered by partici-
pants will be logged. These data are stored in a protected health infor-
mation (PHI)-protected database (REDCap) and then integrated with the
neuroimaging data.
As one of the “Human Connectome Studies Related to Human Dis-
ease”, all the data will ultimately be shared openly via the Human Con-
nectome Project database (https://db.humanconnectome.org).
Neuroimaging and behavioral data will be downloaded from Flywheel
and then reuploaded to the Connectome Coordinating Facility in batches
ranging from 17 to 50 subjects quarterly throughout the period of data
acquisition. Data will be released in the second quarter of 2022. Similarly
to all other Connectomes Related to Human Disease projects, The Con-
nectome Coordinating Facility will run the same processing pipeline
previously run on the HCP-HYA release and the upcoming HCP Lifespan.
In summary, this pipeline includes: structural, functional, multi-Run
ICAFIX, MSM-All and diffusion preprocessing as well as task analysis
where applicable (Glasser et al., 2013; Harms et al., 2018). They will then
distribute the raw and preprocessed image files for all imaging modal-
ities. Quality controls will be performed at the Connectome Coordinating
Facility following a set of best practices developed internally and avail-
able for consultation to study Investigators.85. Quality control
In the following sections we present an overview of the imaging data
from a representative sample of 29 healthy control participants from
HCP-DES (13 females, mean age ¼ 28.19  4.85, min: 21, max: 35).
Preprocessing of structural, functional and diffusion data was conducted
with the minimal preprocessing HCP pipelines version 3.27.0 (Glasser
et al., 2013). This preprocessing includes cortical and subcortical seg-
mentation of structural images, realignment, EPI distortion correction
and surface-based registration of functional data, and mapping of all data
to grayordinate space. For diffusion data, this also includes eddy current,
motion and susceptibility distortion correction. The HCP-DES takes
advantage of its high-resolution multimodal structural scans to perform
registration to grayordinate space and file conversion to the CIFTI format.
This allows combined cortical surface and subcortical volume analyses.
We expect the adoption of CIFTI to boost the power of functional analyses
and improve comparisons across participants.5.1. Resting state
Resting state functional data had good signal-to-noise ratio (SNR;
grayordinate mean ¼ 85.34  38.42). We used MELODIC (Multivariate
Exploratory Linear Decomposition into Independent Components)
version 3.15, part of FSL (FMRIB’s Software Library, www.fmrib.ox.ac.
uk/fsl). The following pre-processing was applied to the input data:
masking of non-brain voxels; voxel-wise de-meaning of the data; nor-
malisation of the voxel-wise variance. Pre-processed data were whitened
and projected into a 25-dimensional subspace using Principal Compo-
nent Analysis. The whitened observations were decomposed into sets of
vectors which describe signal variation across the temporal domain
(time-courses), the session/subject domain and across the spatial domain
(maps) by optimizing for non-Gaussian spatial source distributions using
a fixed-point iteration technique (Hyv€arinen, 1999). Estimated Compo-
nent maps were divided by the standard deviation of the residual noise
and thresholded by fitting a mixture model to the histogram of intensity
values (Beckmann and Smith, 2004). MELODIC successfully identified
well-established networks, such as the default mode, salience, visual and
motor (Fig. 3).
5.2. Emotion
The Emotion task had good SNR (grayordinate mean ¼ 99.53 
50.06). Subject-level analysis was conducted using the HCP pipelines and
was entirely constrained to grayordinates. In summary, a 2 mm
smoothing was applied and a GLM analysis was run using FSL FEAT
(Woolrich et al., 2001) including as regressors the Faces and Shapes
blocks of the task, each convolved with a double-gamma hemodynamic
function and their first order temporal derivatives. The contrast Faces >
Shapes was then analyzed at the group level using FSL PALM (Winkler
et al., 2014). To account for the topological differences of cortical and
subcortical components of the CIFTI dense file, inference from both
representations was computed separately by using 10,000 permutations
with sign-flipping. Results were considered significant when Bonferroni
corrected p < 0.05 at the cluster level. Matching of faces versus shapes
showed significant activations in the bilateral dorsolateral prefrontal and
occipital cortices, in the fusiform gyrus and in the amygdalae (Fig. 4).5.3. Gambling
The Gambling task had good SNR (grayordinate mean ¼ 93.86 
35.31). Analysis of this task was conducted as reported above, with the
two events of interest being win and loss trials. The contrast Win > Loss
was then analyzed at the group level. The win of money versus loss
showed significant activations in the bilateral dorsolateral prefrontal,
parietal and occipital cortices, and in the striatum (Fig. 5).
Fig. 4. Summary of representative functional results for the “Emotion” task. We show a diagram summarizing task design (top left), greyordinate-wise temporal SNR
(top right). For the Negative Faces > Shapes contrast at the group level we show the effect size (Cohen d, bottom left) and significant activations (bottom right).
Abbreviations: SNR ¼ signal to noise ratio; FWE ¼ family-wise error correction.
Fig. 3. Summary of representative functional results for the resting state scan. We show a diagram summarizing task design (top left), greyordinate-wise temporal SNR
(top right) and the spatial weights (z-scores) for four canonical functional networks identified by independent component analysis (bottom left and bottom right).
Abbreviations: PA ¼ posterior-anterior phase encoding; AP ¼ anterior-posterior phase encoding; SNR ¼ signal to noise ratio; DMN ¼ default mode network.
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The continuous performance task had good SNR (grayordinate mean
¼ 92.59 45.66). Analysis of this task was conducted as reported above,
with the two modeled events being the consecutive and non-consecutive
yellow letters. The contrast consecutive letters > Baseline was then9analyzed at the group level. The recognition of a target letter was asso-
ciated with significant activation in the bilateral dorsolateral prefrontal,
parietal, motor, temporal and insular cortices, and in the striatum and
cerebellum (Fig. 6).
Fig. 6. Summary of representative functional results for the “Continuous Performance” Task. We show a diagram summarizing task design (top left), greyordinate-
wise temporal SNR (top right). For the Target > Baseline contrast at the group level we show the effect size (Cohen d, bottom left) and significant activations (bottom
right).
Abbreviations: SNR ¼ signal to noise ratio; FWE ¼ family-wise error correction.
Fig. 5. Summary of representative functional results for the “Gambling” task. We show a diagram summarizing task design (top left), greyordinate-wise temporal SNR
(top right). For the Reward > Punishment contrast at the group level we show the effect size (Cohen d, bottom left) and significant activations (bottom right).
Abbreviations: SNR ¼ signal to noise ratio; FWE ¼ family-wise error correction.
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For 5 subjects, diffusion data could not be collected, so in the
remaining 24 participants (12 females, mean age ¼ 28.31, min: 21.39,10max: 35.90), we quantified fractional anisotropy (FA) of established
white matter tracts (for the b¼ 1500 s/mm2 shell) by using Reproducible
Tract Profiles (Lerma-Usabiaga et al., 2019b). Briefly, this pipeline per-
formed constrained spherical deconvolution modeling on the
Fig. 7. doFractional anisotropy along white matter fiber tracts in our representative sample. Using reproducible tract profiles (Lerma-Usabiaga et al., 2019b), we show
the group level mean (red line) and SD (shaded area) of FA at 100 equally spaced intervals along 10 tracts (left and right).
Abbreviations: CC ¼ corpus callosum; Cing. ¼ cingulum, FA ¼ fractional anisotropy; FOF ¼ fronto-occipital fasciculus; HCP-DES ¼ human connectome project for
disordered emotional states; ILF ¼ inferior longitudinal fasciculus; SLF ¼ superior longitudinal fasciculus; SD ¼ standard deviation.
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(Tournier et al., 2019), followed by whole brain white matter streamlines
estimation using ensemble tractography and linear fascicle evaluation
(Pestilli et al., 2014; Takemura et al., 2016). Then, a modified version of
automated fiber quantification (Yeatman et al., 2012) was used to
segment streamlines into tracts based on regions of interest. Mean FA
varied between 0.43 and 0.65, with a SD across subjects between 0.03
and 0.07, depending on the tract. Profiles of FA along the tract were
consistent between subjects (Fig. 7).
6. Comparison with available HCP data
In the following section we compare imaging data from the sample
outlined above with data from a matched sample of 29 healthy controls
from the HCP Healthy Young Adult (HYA) data release (13 females, mean
age ¼ 27.72  4.57, min: 22, max: 36). This data was collected on a
custom Siemens Skyra “Connectom” scanner (see Barch et al., 2013; Van
Essen et al., 2013 for full protocol details), preprocessed with the HCP
pipelines and made openly available through ConnectomeDB (htt
ps://db.humanconnectome.org/). After downloading the data, we
repeated the steps outlined in the previous section to compare the
HCP-HYA and HCP-DES datasets. Our goal was to provide a preliminary
outlook on the generalizability of findings from one dataset to the other,
given that, despite all efforts undertaken to minimize discrepancies, they
were acquired on different scanners, at different sites and with different
protocols. Concerning behavior and self-reports, Supplementary Table 2
draws a comparison between each of the measures collected in HCP-DES11and corresponding measures released in the HCP-HYA dataset. Given the
differences in the aims and target populations between the two datasets,
the same exact questionnaires and tests were not always used. However,
in this table we suggest which measurements from the HCP Healthy
Young Adult overlap in terms of domains and contain similar items to the
ones we use in HCP-DES.
6.1. Resting state
Compared to HCP-HYA, resting state functional data from HCP-DES
had higher SNR (grayordinate mean ¼ 99.53  50.06 and 49.10 
25.85 respectively). In both datasets, MELODIC identified well-
established networks with comparable characteristics, such as the
default mode network (Fig. 8).
6.2. Emotion
Compared to HCP-HYA, “Emotion” task functional data from HCP-
DES had higher SNR (grayordinate mean ¼ 85.34  38.42 and 56.51
 26.74 respectively). In both datasets, matching of faces versus shapes
showed significant activations in the bilateral dorsolateral prefrontal and
occipital cortices, in the fusiform gyrus and in the amygdalae (Fig. 9).
6.3. Gambling
Compared to HCP-HYA, “Gambling” task functional data from HCP-
DES had higher SNR (grayordinate mean ¼ 93.86  35.31 and 56.38
Fig. 9. Comparison of representative functional
results for the “Emotion” task between HYA and
DES. We show a diagram summarizing
greyordinate-wise temporal SNR (top). For the
Negative Faces > Shapes contrast at the group level
we show the effect size (Cohen d, middle) and sig-
nificant activations (bottom).
Abbreviations: HYA ¼ healthy young adult data
release; DES ¼ human connectome project for
disordered emotional states; SNR ¼ signal to noise
ratio; FWE ¼ family-wise error correction.
Fig. 8. Comparison of representative functional
results for the resting state scan between HYA and
DES. We show a diagram summarizing
greyordinate-wise temporal SNR (top) and the
spatial weights (z-scores) for the default mode
network identified by independent component
analysis (bottom).
Abbreviations: HYA ¼ healthy young adult data
release; DES ¼ human connectome project for
disordered emotional states; SNR ¼ signal to noise
ratio; DMN ¼ default mode network.
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Fig. 10. Comparison of representative functional
results for the “Gambling” task between HYA and
DES. We show a diagram summarizing
greyordinate-wise temporal SNR (top). For the
Reward > Punishment contrast at the group level
we show the effect size (Cohen d, middle) and sig-
nificant activations (bottom).
Abbreviations: HYA ¼ healthy young adult data
release; DES ¼ human connectome project for
disordered emotional states; SNR ¼ signal to noise
ratio; FWE ¼ family-wise error correction.
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significant activations in the bilateral dorsolateral prefrontal, parietal
and occipital cortices, and in the striatum (Fig. 10).
6.4. Continuous performance
As a comparison for the HCP-DES “Continuous Performance” task, we
chose the HCP-HYA “Working Memory” task since both were designed to
engage the construct of working memory. To quantify task activations,
we chose to focus on the 0-back condition of this task. In this condition,
participants were shown a stimulus at the beginning of a task block and
were instructed to press a button every time the stimulus was presented.
We compare this condition to the button press in response to two
consecutive yellow letters in HCP-DES.
Data from HCP-DES had higher SNR (grayordinate mean ¼ 92.59 
45.66 and 54.24  26.20 respectively).
In both datasets, the recognition of the target stimulus was associated
with significant activation in the bilateral dorsolateral prefrontal, pari-
etal, motor, temporal and insular cortices, and in the striatum and cer-
ebellum (Fig. 11).136.5. Diffusion
Tract profiles and standard deviations of FA measurements along the
tract were comparable between the HCP-DES and HCP-HYA datasets.
Mean FAwas consistently higher for the HCP-HYA dataset, because of the
different b-values used in the acquisition/FA calculation (1000 s/mm2
for HCP-HYA compared to 1500 s/mm2 for HCP-DES) (Lerma-Usabiaga
et al., 2019a) (Fig. 12).
7. Intended use and limitations
The current prevalent framework in psychiatry relies on symptoms to
formulate categorical diagnoses. In contrast, the HCP-DES will contribute
to a novel, dimensional taxonomy informed by systems neuroscience
through the multimodal quantification of the brain networks that un-
derlie disordered emotional states. Measuring brain connectivity,
behavior and clinical symptoms will permit us to examine the relations
among these units of analysis and to predict outcomes relevant to
disability and burden of illness over one year. Finally, this trans-
diagnostic approach to emotional disorders will allow us to develop data-
driven, machine-learning methods to elucidate how disruption in the
negative valence, positive valence and cognitive systems combine to
form naturally organized clusters of patients.
Fig. 11. Comparison of representative functional
results for the “Working Memory” HYA task and
the “Continuous Performance” DES task. We show
a diagram summarizing greyordinate-wise tempo-
ral SNR (top). For the Target Stimulus > Baseline
contrast at the group level we show the effect size
(Cohen d, middle) and significant activations
(bottom).
Abbreviations: HYA ¼ healthy young adult data
release; DES ¼ human connectome project for
disordered emotional states; SNR ¼ signal to noise
ratio; FWE ¼ family-wise error correction.
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through the Connectome Coordinating Facility. The multimodal nature
of the HCP-DES imaging will help answer basic scientific questions
concerning the relations between structural and functional connectomes
in mood disorders. Of particular interest to multi-site collaborations,
measures collected in HCP-DES show a substantial overlap with those in
other HCP datasets. Therefore, the data will contribute to efforts to
quantify the naturally occurring heterogeneity in brain connectivity
across normative and clinical populations.
While this project offers a number of advances in characterizing
emotional disorders, it is important to consider the limitations that
restrict its scope and generalizability. In the HCP-DES, participants on
psychiatric medication will be excluded in order to examine patterns of
brain connectivity without the effect of medication. Thus, the HCP-DES
will be most suited to make inferences about brain changes which
might be different from the ones of patients currently receiving
treatment.
Additionally, we anticipate technical challenges in merging data from
the HCP-DES project with other projects that acquired brain imaging data
on a different model of scanner with some important differences in the
scanning protocol. Concerning the harmonization of the data collected by14HCP-DES within the HCP consortium, first of all it is important to note
that three other HCP Connectomes Related to Human Disease are
currently investigating other aspects of mood disorders: anxious misery,
major depression in teenagers and predictors of treatment response to
fast-acting therapies (see https://www.humanconnectome.org/disease-s
tudies). These other studies target a similar population to HCP-DES and
are acquiring data on Siemens scanners similar to the Skyra “Con-
nectom”. Therefore, they will provide another useful benchmark to test
generalizability of findings or to runmeta- andmega-analyses across sites
collecting similar measures (e.g. questionnaires of symptom severity).
For merging of these datasets, recently developed algorithms to correct
for site effects will likely be needed (see for example COMBAT, (Fortin
et al., 2017; Johnson et al., 2007). However, it is important to highlight
that besides technical challenges, collection of data at different sites also
allows to explore how findings generalize across device vendors and
populations. In this respect, our preliminary data show that overlapping
task activations and comparable resting state networks as well as tract
profiles can be detected from the data collected on the HCP-DES GE
Discovery scanner and the Central Connectome Facility Siemens Skyra
“Connectom”. Interestingly, temporal SNR was generally higher in
HCP-DES especially in subcortical structures, potentially due to a lower
Fig. 12. Comparison of fractional anisotropy along white matter fiber between the HCP-DES and HCP-HYA datasets. Using reproducible tract profiles (Lerma-Usa-
biaga et al., 2019b), we show the group level mean (red ¼ HCP-DES, green ¼ HCP-HYA) and SD (shaded area) of FA at 100 equally spaced intervals along 10 tracts
(left and right).
Abbreviations: CC ¼ corpus callosum; Cing. ¼ cingulum, HCP-HYA ¼ healthy young adult data release; HCP-DES ¼ human connectome project for disordered
emotional states, FA ¼ fractional anisotropy; FOF ¼ fronto-occipital fasciculus; ILF ¼ inferior longitudinal fasciculus; SLF ¼ superior longitudinal fasciculus; SD ¼
standard deviation.
L. Tozzi et al. NeuroImage 214 (2020) 116715multiband acquisition factor (6 compared to 8 in HCP-HYA).
To conclude, in the Human Connectome Project for Disordered
Emotional States we will obtain cutting-edge multimodal imaging, self-
reports and behavioral measures in a rich dataset that will be made
publicly available. This project is designed to assess how brain circuits
relevant to the RDoC domains of negative valence, positive valence,
cognitive systems and cross-cutting elements are disrupted in anxiety and
depression.
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